{
    "title": "Big pharma company AbbVie made $114bn from a miracle arthritis drug called Humira AFTER its patent ran out by tying competitors up in litigation - but patients will finally get access to cheaper versions this year",
    "url": "https://www.dailymail.co.uk/news/article-11697851/Big-pharma-company-AbbVie-114bn-Humira-tying-competitors-litigation.html",
    "date": "2023-01-31",
    "keywords": [
        "market",
        "humira",
        "drug",
        "abbvie",
        "company",
        "patent",
        "biosimilar",
        "richard",
        "gonzalez",
        "medicare",
        "system",
        "pricing",
        "percent",
        "week",
        "amgen",
        "price",
        "disease",
        "colitis",
        "number",
        "use",
        "year",
        "ceo",
        "series",
        "yearrelief",
        "sight",
        "amjevita",
        "wave",
        "insurance",
        "mettawa",
        "illinois",
        "arthritis",
        "psoriasishumira",
        "treatment",
        "arthritissince",
        "psoriasis",
        "skin",
        "conditionsabbvie",
        "york",
        "half",
        "syringe",
        "litany",
        "effort",
        "impunity",
        "help",
        "turn",
        "costone",
        "study",
        "tosince",
        "executive",
        "bill",
        "conference",
        "behindthe",
        "law",
        "companys",
        "committee",
        "pricescountless",
        "bristol",
        "merck",
        "way",
        "poster",
        "child",
        "industry",
        "expert",
        "washington",
        "university",
        "rachel",
        "sachs",
        "line",
        "form",
        "rome",
        "harvard",
        "school",
        "researcher"
    ],
    "category": [
        "news"
    ]
}